DFG · DE · DFG
The Clinical Trials Programme funds patient-oriented clinical research in Germany, including interventional clinical studies (phase II feasibility studies and phase III interventional trials) and observational trials, aiming to prove the efficacy of new therapeutic, diagnostic, or prognostic methods. Funding covers staff, equipment, consumables, travel, and other trial-related costs. Feasibility studies have a maximum duration of 36 months, while interventional and observational trials are initially funded for 36 months with possible renewal.
Researchers in Germany who have completed their academic training (a doctorate as a rule) are eligible.
Rolling / ongoing
3 form file(s) downloaded; 11 writing prompts; 35 fields/sections; page limits totaling ~20; heavy — expect a full proposal pack
Where each item on this page was read from, so every claim can be verified against the original. “Official ↗” opens the funder page the value came from; anything we could not reach or parse is listed under Not captured / obstacles below.
| Curated item | Value in this record | Source |
|---|---|---|
| Funding agency | DFG | Official page ↗ |
| Country / funding source | DE · DFG | Official page ↗ |
| Deadline | Rolling — no fixed deadline — official page lists it as rolling/ongoing | Official page ↗ |
| Funding amount | Not stated on the official page | Official page ↗ |
| Eligibility | 6 structured dimensions — see the eligibility panel above | Official page ↗ |
Data is collected from official funder pages only. Figures are machine-curated (rule + LLM where noted) and should be re-verified on the linked source before use.